Your browser doesn't support javascript.
loading
Bone turnover markers and muscle decay indicator in patients with proximal femur fracture - a case-control study.
Lapinski, Marcin; Zarnovsky, Krystian; Czarzasta, Katarzyna; Maciag, Bartosz; Maciag, Grzegorz; Adamska, Olga; Mamcarz, Artur; Stolarczyk, Artur.
  • Lapinski M; Department of Orthopedics and Rehabilitation, Medical University of Warsaw, Poland.
  • Zarnovsky K; Department of Orthopedics and Rehabilitation, Medical University of Warsaw, Poland.
  • Czarzasta K; Department of Experimental and Clinical Physiology, Medical University of Warsaw, Poland.
  • Maciag B; Department of Orthopedics and Rehabilitation, Medical University of Warsaw, Poland.
  • Maciag G; Department of Orthopedics and Rehabilitation, Medical University of Warsaw, Poland.
  • Adamska O; Department of Orthopedics and Rehabilitation, Medical University of Warsaw, Poland.
  • Mamcarz A; Department of Internal Medicine and Cardiology, Medical University of Warsaw, Poland.
  • Stolarczyk A; Department of Orthopedics and Rehabilitation, Medical University of Warsaw, Poland.
Reumatologia ; 62(2): 121-127, 2024.
Article en En | MEDLINE | ID: mdl-38799774
ABSTRACT

Introduction:

Fracture of the proximal femur is common in elderly patients, in fact threatening their lives. Age-related sarcopenia may be involved in the imbalance resulting in the injury. Handy and readily accessible biochemical tests would be useful to assess the musculoskeletal system condition in daily practice. The aim of the study was to determine whether there is any relation between muscle decay and fracture of the proximal femur and to assess bone quality in elderly patients. Material and

methods:

In the study 22 patients who represented the treatment group were hospitalized due to proximal femur fracture. Eighteen patients from the control group with no fracture in their history were admitted to the Internal Medicine Department. Anyone treated for osteoporosis, immune disease affecting protein balance, neoplasm, mental illness, heart failure, or myocardial infarction was excluded from the study. In every case a blood sample from an elbow vein was drawn, collected in EDTA-K2 tubes, and then centrifuged to separate plasma from the whole blood. Subsequently, the concentrations of C-terminal cross-linked telopeptide of type I collagen (CTX-I), sex hormone binding globulin (SHBG) and creatine kinase (CK) in plasma were determined using commercial enzyme-linked immunosorbent assays.

Results:

The CK plasma concentration differed between the patient groups (p = 0.011). The SHBG plasma concentration was significantly higher in the treatment group (p = 0.006), whereas a slight difference in CTX-I plasma concentration between the groups was found (p = 0.038). No significant correlations between plasma CK, SHBG or CTX-I were found (p > 0.05).

Conclusions:

Creatine kinase is actually not an appropriate marker for the clinical assessment of muscle tissue quality in patients with or at risk of proximal femur fracture. Analyzing the quality of bone tissue, we can conclude it was poorer in patients with proximal femur fracture than in the control group.
Palabras clave